Attached files

file filename
8-K - NAVIDEA BIOPHARMACEUTICALS, INC.v206583_8-k.htm
EX-10.1 - NAVIDEA BIOPHARMACEUTICALS, INC.v206583_ex10-1.htm
Exhibit 10.2

SCHEDULE IDENTIFYING MATERIAL DIFFERENCES BETWEEN
EMPLOYMENT AGREEMENTS
BETWEEN NEOPROBE CORPORATION AND
THE INDIVIDUALS LISTED BELOW

 
 
 
Commencement
Date
 
 
Termination
Date
 
 
 
2011 Base Salary
 
 
 
Amount of Severance
 
 
Amount of Severance
upon change of control
           
Frederick O. Cope
 
1/1/2011
12/31/2012
$245,000
$245,000
 
$367,500
 
Mark J. Pykett
 
11/15/2010
12/31/2011
$325,000
$162,500
Greater of: (a) 30 months
salary; or (b) $650,000
 
Brent L. Larson
1/1/2011
12/31/2012
$207,000
 
$207,000
$310,500
Anthony K. Blair
1/1/2011
12/31/2012
$195,000
$195,000
$292,500